4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-017562
Chief Strategy Officer sold 1,895 shares at $6.84 ($12,962)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Nayak Sanjay · Chief Strategy Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-24 | Sale : show line 1 in the form 10b5-1 | −1,895 | $6.84 | $12,962 | 283,485 | D |
| Open-market sales · 1,895 sh · avg $6.84 · $12,962 | ||||||
Loading xslF345X05/tm257640-1_4seq1.xml…